Skip to main content
Erschienen in: Cancer Cell International 1/2013

Open Access 01.12.2013 | Retraction Note

Retraction Note: The stem cell factor antibody enhances the chemotherapeutic effect of adriamycin on chemoresistant breast cancer cells

verfasst von: Neil D Jelly, Issam I Hussain, Jennifer Eremin, Oleg Eremin, Mohamed El-Sheemy

Erschienen in: Cancer Cell International | Ausgabe 1/2013

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN
Hinweise
The online version of the original article can be found at 10.​1186/​1475-2867-12-21

Retraction

This article has been retracted [1] by the authors because errors were noted in the methodology employed in the experiments which invalidate the results reported. The authors apologise for any inconvenience caused.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://​creativecommons.​org/​licenses/​by/​2.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.
download
DOWNLOAD
print
DRUCKEN
Literatur
1.
Zurück zum Zitat Jelly ND, Hussain II, Eremin J, Eremin O, El-Sheemy M: The stem cell factor antibody enhances the chemotherapeutic effect of adriamycin on chemoresistant breast cancer cells. Cancer Cell Int. 2012, 12: 21-10.1186/1475-2867-12-21.PubMedCentralCrossRefPubMed Jelly ND, Hussain II, Eremin J, Eremin O, El-Sheemy M: The stem cell factor antibody enhances the chemotherapeutic effect of adriamycin on chemoresistant breast cancer cells. Cancer Cell Int. 2012, 12: 21-10.1186/1475-2867-12-21.PubMedCentralCrossRefPubMed
Metadaten
Titel
Retraction Note: The stem cell factor antibody enhances the chemotherapeutic effect of adriamycin on chemoresistant breast cancer cells
verfasst von
Neil D Jelly
Issam I Hussain
Jennifer Eremin
Oleg Eremin
Mohamed El-Sheemy
Publikationsdatum
01.12.2013
Verlag
BioMed Central
Erschienen in
Cancer Cell International / Ausgabe 1/2013
Elektronische ISSN: 1475-2867
DOI
https://doi.org/10.1186/1475-2867-13-96

Weitere Artikel der Ausgabe 1/2013

Cancer Cell International 1/2013 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.